Rockpointe

Rockpointe


Achieving New Treatment Goals in Multiple Sclerosis: Strategies for Initial Treatment Selection and Patient Engagement

The clinical benefits of early, aggressive treatment in MS have been demonstrated via slower progression of disease and improved patient quality of life. Disease-free status, or “no evidence of disease activity” (NEDA), is now a realistic treatment goal. However, with 15 current FDA-approved disease-modifying therapies (DMTs) available, it is challenging to personalize selection of the optim...
Rockpointe

Cardiovascular Risk Reduction in T2DM: Applying Trial Data in Cardiology Practice

Cardiovascular disease (CVD) is a leading cause of death in patients with type 2 diabetes mellitus (T2DM). The presence of diabetes also markedly increases the risk of 1-year adverse clinical outcomes (hospitalizations, mortality) in outpatients with heart failure. Multiple clinical trials have been undertaken to address critical issues in the management of CVD and T2DM. Trial findings have show...
USF Health and Rockpointe

Common Musculoskeletal Complaints from Head to Toe

Musculoskeletal pain is very common, especially in primary care settings. However, surveys have shown that many primary care providers (PCPs) find it challenging to perform the proper physical examinations for accurate musculoskeletal pain diagnoses. Therefore, they rely on imaging and unnecessary referrals to specialists, which increase healthcare costs and create unnecessary delays in optimal ...
Rockpointe

CVD and Renal Disease in T2DM: Individualizing Therapeutic Options to Reduce Comorbid Risk

Type 2 diabetes mellitus (T2DM) continues to pose a major public-health problem. This CME activity will explore the effects of T2DM and its most common comorbidities, specifically CVD and renal complications. CVD is the leading cause of death in T2DM patients, and cardiovascular complications also reduce patient quality of life. Chronic kidney disease, often underdiagnosed until later stages, al...
Rockpointe

Developing an Effective Treatment Plan: Opioid- and Nonopioid-based Treatment Options for Acute and Chronic Pain Management

Pain is a significant public-health problem, affecting more than 100 million adults in the US and causing significant reductions in patient quality of life. The use of narcotic medications for pain management has increased dramatically in the US over the past two decades. However, pain patients are often undertreated due to a variety of physician- and patient-related concerns and barriers. De...
Rockpointe

FIGHTING THE UPHILL BATTLE: Current Evidence in Obesity Management

The current obesity epidemic shows no signs of slowing down and the factors driving it are numerous, including patient and clinician attitudes toward weight loss, a lack of clinician familiarity with guidelines, a lack of effective long-term weight-loss options, and a hesitancy among physicians to recognize obesity as a medical condition and discuss weight with their patients. Recent evidence de...
Boston University School of Medicine and Rockpointe

Improving Outcomes for Patients with Severe Hypercholesterolemia

Hypercholesterolemia, particularly low-density lipoprotein cholesterol (LDL-C) elevation, is a major driver of atherosclerotic cardiovascular disease (ASCVD). Lipid-lowering therapies (mainly in combination with statins) are the primary treatment approach to lower LDL-C and reduce CVD risk. However, intensive statin therapy lowers CVD risk only by ~50%, leaving many patients at excessively high ...
Rockpointe

ON THE FRONT LINE OF A CRISIS: Improving the Care and Education of Patients with Opioid Use Disorder

Opioid use disorder (OUD) continues to claim a significant number of US lives each year, and that number is predicted to escalate in the years to come. All healthcare practitioners (HCPs) – including physicians, nurses, and pharmacists – on the interdisciplinary OUD management team have major roles to play in combating the opioid epidemic. However, knowledge and practice gaps remain related ...
Rockpointe

Optimizing Care for Hereditary Angioedema: Strategies for Personalizing Treatment Selection and Effective Patient Communication

Hereditary angioedema (HAE) is a rare genetic disease which causes sporadic swelling in the face, neck, limbs, and abdomen. The frequency, severity, and character of attacks can vary widely, and patients with HAE frequently have delayed diagnoses or are misdiagnosed. Effective targeted agents and current evidence-based recommendations on their use are often not considered. Regular monitoring of ...
Rockpointe

Preventive Health for Adults: Current Screening Guidelines for Heart Disease and Cancer

To achieve the Triple Aim of Healthcare (better care, better health, and lower costs), it is critical that primary care providers be aware of appropriate means of disease prevention and detection, particularly for heart disease and cancer, the two leading causes of death in the US. This session is specially designed for internists, family practitioners, and other primary care clinicians. Aft...
Rockpointe

Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice

Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of death and mortality in the United States, and elevated serum low-density lipoprotein cholesterol (LDL-C) is a widely-recognized risk factor. Because most initial presentations of symptoms of heart disease are referred to interventional cardiologists, these clinicians play a central role in managing patients with clinical ASCVD ...
Rockpointe

Understanding Changes in Medicare Reimbursement Under the Medicare Access and CHIP Reauthorization Act (MACRA)

ACA, MACRA and recent policy is rapidly accelerating the shift of healthcare payment from volume- to value-based reimbursement. This session will explore the waters of payment transformation through the use of data and essential strategies and technologies associated with alternative payment models (APMs) and the merit-based incentive payment system (MIPS). EDUCATIONAL OBJECTIVES - At the con...
Rockpointe

Updates for Migraine Management in Primary Care

Based solely on clinical evaluation, the diagnosis of migraine can be challenging for clinicians. Its management typically requires lifestyle and trigger management, along with acute, preventive, or combination treatments. Recent migraine research has focused on the role of calcitonin gene-related peptide (CGRP), which is released in significant amounts during an acute attack and is chronically ...
Rockpointe

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.